Matches in Wikidata for { <http://www.wikidata.org/entity/Q65474668> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q65474668 description "clinical trial" @default.
- Q65474668 description "ensayu clínicu" @default.
- Q65474668 description "klinisch onderzoek" @default.
- Q65474668 description "клінічне випробування" @default.
- Q65474668 name "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 name "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 type Item @default.
- Q65474668 label "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 label "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 prefLabel "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 prefLabel "Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide" @default.
- Q65474668 P1050 Q65474668-8D17D482-867C-4DE6-8E84-1C4C92954D7F @default.
- Q65474668 P1132 Q65474668-A422DAA7-4176-4898-A828-D35045BD3075 @default.
- Q65474668 P1476 Q65474668-E1C8C1C5-E905-47C9-9CBC-B122B1381898 @default.
- Q65474668 P17 Q65474668-26BE0399-99E0-4D7B-8966-8D865808182F @default.
- Q65474668 P17 Q65474668-75CAA55E-0A56-4EBC-94E6-2B08DE93BDAD @default.
- Q65474668 P2899 Q65474668-472DCC3B-2077-4480-A063-92E0ABA46F1D @default.
- Q65474668 P3098 Q65474668-8E955881-A599-46AF-96A0-FB0023376104 @default.
- Q65474668 P31 Q65474668-121CABD7-9A9C-425C-8ABF-440A06E5BA20 @default.
- Q65474668 P4844 Q65474668-5ECD75A7-79A6-4372-A340-D4091F570E54 @default.
- Q65474668 P4844 Q65474668-8C56DAE0-616F-4CEF-8652-848076E9EF79 @default.
- Q65474668 P4844 Q65474668-AA5AF4B5-FCC5-4E94-A9A2-D00E490400AE @default.
- Q65474668 P4844 Q65474668-DEFC2637-B158-438E-A38C-6D12F93D2492 @default.
- Q65474668 P580 Q65474668-7DB9C083-AAFD-4866-ACD6-8F5AF417D300 @default.
- Q65474668 P582 Q65474668-3D2E1078-37E0-43BD-BC54-CE485D631F11 @default.
- Q65474668 P6099 Q65474668-98B0C5F4-DBE8-454E-9CB9-F82D0F8F49D0 @default.
- Q65474668 P6153 Q65474668-A8913D3E-94A0-45CB-8C62-2363AAEDA2D5 @default.
- Q65474668 P8363 Q65474668-5E920F64-0F4F-4E03-9415-4A3B7A1D7B8E @default.
- Q65474668 P1050 Q41861 @default.
- Q65474668 P1132 "+198" @default.
- Q65474668 P1476 "An Open-label, Multicenter Study to Evaluate the Efficacy and Tolerability of a 4 Week Therapy With the Fixed Dose Combination of Valsartan 160 mg Plus HCTZ 25 mg in Hypertensive Patients Not Adequately Responding to a 4 Week Therapy With the Free Combination of an Angiotensin Receptor Blocker (Candesartan 32 mg) Plus HCTZ 25 mg" @default.
- Q65474668 P17 Q183 @default.
- Q65474668 P17 Q39 @default.
- Q65474668 P2899 "+18" @default.
- Q65474668 P3098 "NCT00360178" @default.
- Q65474668 P31 Q30612 @default.
- Q65474668 P4844 Q27075664 @default.
- Q65474668 P4844 Q415970 @default.
- Q65474668 P4844 Q50430355 @default.
- Q65474668 P4844 Q7912612 @default.
- Q65474668 P580 "2006-07-01T00:00:00Z" @default.
- Q65474668 P582 "2006-12-01T00:00:00Z" @default.
- Q65474668 P6099 Q42824827 @default.
- Q65474668 P6153 Q507154 @default.
- Q65474668 P8363 Q78089383 @default.